Junker N - Search Results

1

The immune system strikes back: cellular immune responses against indoleamine 2,3-dioxygenase.

Sørensen RB, Berge-Hansen L, Junker N, Hansen CA, Hadrup SR, Schumacher TN, Svane IM, Becker JC, thor Straten P, Andersen MH. Sørensen RB, et al. Among authors: junker n. PLoS One. 2009 Sep 7;4(9):e6910. doi: 10.1371/journal.pone.0006910. PLoS One. 2009. PMID: 19738905 Free PMC article.

2

The immunodominant HLA-A2-restricted MART-1 epitope is not presented on the surface of many melanoma cell lines.

Sørensen RB, Junker N, Kirkin A, Voigt H, Svane IM, Becker JC, thor Straten P, Andersen MH. Sørensen RB, et al. Among authors: junker n. Cancer Immunol Immunother. 2009 May;58(5):665-75. doi: 10.1007/s00262-008-0588-0. Epub 2008 Oct 1. Cancer Immunol Immunother. 2009. PMID: 18828018

3

Therapeutic cancer vaccines in combination with conventional therapy.

Andersen MH, Junker N, Ellebaek E, Svane IM, Thor Straten P. Andersen MH, et al. Among authors: junker n. J Biomed Biotechnol. 2010;2010:237623. doi: 10.1155/2010/237623. Epub 2010 Jun 29. J Biomed Biotechnol. 2010. PMID: 20617155 Free PMC article. Review.

4

Bimodal ex vivo expansion of T cells from patients with head and neck squamous cell carcinoma: a prerequisite for adoptive cell transfer.

Junker N, Andersen MH, Wenandy L, Dombernowsky SL, Kiss K, Sørensen CH, Therkildsen MH, Von Buchwald C, Andersen E, Straten PT, Svane IM. Junker N, et al. Cytotherapy. 2011 Aug;13(7):822-34. doi: 10.3109/14653249.2011.563291. Epub 2011 Mar 24. Cytotherapy. 2011. PMID: 21428850

5

Characterization of ex vivo expanded tumor infiltrating lymphocytes from patients with malignant melanoma for clinical application.

Junker N, Thor Straten P, Andersen MH, Svane IM. Junker N, et al. J Skin Cancer. 2011;2011:574695. doi: 10.1155/2011/574695. Epub 2011 Jun 18. J Skin Cancer. 2011. PMID: 21773037 Free PMC article.

6

Characterization and comparison of 'standard' and 'young' tumour-infiltrating lymphocytes for adoptive cell therapy at a Danish translational research institution.

Donia M, Junker N, Ellebaek E, Andersen MH, Straten PT, Svane IM. Donia M, et al. Among authors: junker n. Scand J Immunol. 2012 Feb;75(2):157-67. doi: 10.1111/j.1365-3083.2011.02640.x. Scand J Immunol. 2012. PMID: 21955245 Free article.

7

Tumor associated antigen specific T-cell populations identified in ex vivo expanded TIL cultures.

Junker N, Kvistborg P, Køllgaard T, Straten Pt, Andersen MH, Svane IM. Junker N, et al. Cell Immunol. 2012;273(1):1-9. doi: 10.1016/j.cellimm.2011.12.004. Epub 2011 Dec 17. Cell Immunol. 2012. PMID: 22230732

8

Dissection of T-cell antigen specificity in human melanoma.

Andersen RS, Thrue CA, Junker N, Lyngaa R, Donia M, Ellebæk E, Svane IM, Schumacher TN, Thor Straten P, Hadrup SR. Andersen RS, et al. Among authors: junker n. Cancer Res. 2012 Apr 1;72(7):1642-50. doi: 10.1158/0008-5472.CAN-11-2614. Epub 2012 Feb 6. Cancer Res. 2012. PMID: 22311675

9

A promiscuous survivin-derived T-cell epitope restricted to the HLA-A3 super-type alleles.

Junker N, Munir S, Kvistborg P, Straten Pt, Svane IM, Andersen MH. Junker N, et al. J Invest Dermatol. 2012 Aug;132(8):2115-8. doi: 10.1038/jid.2012.109. Epub 2012 Apr 19. J Invest Dermatol. 2012. PMID: 22513782 Free article. No abstract available.

10

Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients.

Ellebaek E, Iversen TZ, Junker N, Donia M, Engell-Noerregaard L, Met Ö, Hölmich LR, Andersen RS, Hadrup SR, Andersen MH, thor Straten P, Svane IM. Ellebaek E, et al. Among authors: junker n. J Transl Med. 2012 Aug 21;10:169. doi: 10.1186/1479-5876-10-169. J Transl Med. 2012. PMID: 22909342 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

52 results

Search Page